Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Combination Product: mavrilimumab
(D09930)		[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 41 💬
2MAVRILIMUMAB
(D09930)		[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[2] 41, 46 💬
3Mavrilimumab 10 mg
(D09930)		[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
4Mavrilimumab 100 mg
(D09930)		[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
5Mavrilimumab 150 mg
(D09930)		[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
6Mavrilimumab 30 mg
(D09930)		[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
7Mavrilimumab 50 mg
(D09930)		[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬[1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬